Celon Pharma (FRA:8RP) Other Operating Expense : €39.06 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Celon Pharma Other Operating Expense?

Celon Pharma's Other Operating Expense for the three months ended in Sep. 2024 was €10.79 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 was €39.06 Mil.

Celon Pharma's quarterly Other Operating Expense increased from Mar. 2024 (€9.73 Mil) to Jun. 2024 (€10.24 Mil) and increased from Jun. 2024 (€10.24 Mil) to Sep. 2024 (€10.79 Mil).

Celon Pharma's annual Other Operating Expense increased from Dec. 2021 (€28.73 Mil) to Dec. 2022 (€31.57 Mil) but then declined from Dec. 2022 (€31.57 Mil) to Dec. 2023 (€30.42 Mil).

Celon Pharma Other Operating Expense Historical Data

The historical data trend for Celon Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celon Pharma Other Operating Expense Chart

Celon Pharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

17.19

24.97

28.73

31.57

30.42

Celon Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Operating Expense	Get a 7-Day Free Trial															8.68	8.30	9.73	10.24	10.79

Celon Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €39.06 Mil.

Celon Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Celon Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Celon Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celon Pharma SA (FRA:8RP) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

CLN:Poland

Address

Ogrodowa 2A, Kielpin, Lomianki, POL, 05-092

Website

http://www.celonpharma.com

Celon Pharma SA is a Poland based company engages in the research of therapeutic solutions and development, production, distribution, and marketing of specialized generic products. It invests in the development of innovative pharmaceuticals with potential applications in the treatment of cancer, neurological diseases, diabetes and other metabolic disorders. Its products portfolio comprises pills, such as Aromek, Bosentan Celon, Donepex, Ketrel, Lazivir, and Valzek, as well as inhalation powder.

Celon Pharma Headlines

No Headlines